This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Permanently Discontinued

APO-RANITIDINE TABLET 150MG

APOTEX INC

View this drug's full profile page →

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-RANITIDINE TABLET 150MG in Canada?

Yes. APO-RANITIDINE TABLET 150MG has an active shortage reported to Health Canada (last updated September 18, 2019).

Why is APO-RANITIDINE TABLET 150MG not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-RANITIDINE TABLET 150MG be available again?

No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file3 products

Affected strength150MG

Report last updated2018-12-28

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

MINT-RANITIDINE

MINT PHARMACEUTICALS INC

150MG · DIN 02526379

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

MAR-RANITIDINE

MARCAN PHARMACEUTICALS INC

150MG · DIN 02443708

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

MAXIMUM STRENGTH ACID REDUCER WITHOUT PRESCRIPTION

PHARMASCIENCE INC

150MG · DIN 02293471

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

00733059

Strength

150MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

RANITIDINE

Tier

Unrated

Last Updated

2018-12-28

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

APO-RANITIDINE TABLET 150MG has 4 shortage/discontinuation reports on file — this is one of them.

2019-09-18

Active Shortage

Disruption of the manufacture of the drug.

2019-02-13

Permanently Discontinued

Business reasons

2019-01-09

Permanently Discontinued

Business reasons

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244